Wei, F.; Zhang, X.; Yang, S.; Geng, J.; Xie, B.; Ren, Y.; Dai, H.
Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren’s Syndrome Complicated with Interstitial Lung Disease. J. Clin. Med. 2023, 12, 4926.
https://doi.org/10.3390/jcm12154926
AMA Style
Wei F, Zhang X, Yang S, Geng J, Xie B, Ren Y, Dai H.
Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren’s Syndrome Complicated with Interstitial Lung Disease. Journal of Clinical Medicine. 2023; 12(15):4926.
https://doi.org/10.3390/jcm12154926
Chicago/Turabian Style
Wei, Fengqin, Xinran Zhang, Shengnan Yang, Jing Geng, Bingbing Xie, Yanhong Ren, and Huaping Dai.
2023. "Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren’s Syndrome Complicated with Interstitial Lung Disease" Journal of Clinical Medicine 12, no. 15: 4926.
https://doi.org/10.3390/jcm12154926
APA Style
Wei, F., Zhang, X., Yang, S., Geng, J., Xie, B., Ren, Y., & Dai, H.
(2023). Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren’s Syndrome Complicated with Interstitial Lung Disease. Journal of Clinical Medicine, 12(15), 4926.
https://doi.org/10.3390/jcm12154926